Achieving Normoglycemia With Tirzepatide: Analysis of SURPASS 1–4 Trials

OBJECTIVE: Tirzepatide is a novel single-molecule glucose-dependent insulinotropic polypeptide/glucagon-like peptide 1 receptor agonist, which demonstrated unprecedented improvements in glycemic control and body weight reduction, in the SURPASS phase 3 program. In this exploratory analysis, we aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenstock, Julio, Vázquez, Luis, Del Prato, Stefano, Franco, Denise Reis, Weerakkody, Govinda, Dai, Biyue, Landó, Laura Fernández, Bergman, Brandon K., Rodríguez, Angel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620542/
https://www.ncbi.nlm.nih.gov/pubmed/37673061
http://dx.doi.org/10.2337/dc23-0872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620542/
https://www.ncbi.nlm.nih.gov/pubmed/37673061
http://dx.doi.org/10.2337/dc23-0872

Ejemplares similares